Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Discover which HYD ETF fits best for retirement planning with an eye on income stability and diversification. Learn key factors to compare and start building a resilient retirement portfolio.
22,937 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Investors in YMAX face layered fees from a fund-of-funds structure. With a 1.33% expense ratio on top of underlying E...
XRP exchange-traded funds booked their first monthly net outflow after a $1.2 billion rally, signaling a shift in inv...
A popular fallen angel ETF delivers about 6% yield paid monthly by buying bonds downgraded from investment grade. It’...
The NEOS Gold High Income ETF has surged about 24% since its debut, yet investors should weigh the income wrapper tha...
Morgan Stanley’s bitcoin ETF attracted $194 million in its first month, with no net daily outflows, signaling growing...
XRP faces a staged path to higher levels, with Standard Chartered outlining a first milestone near $4 before targetin...
Spot Bitcoin ETFs see roughly $1 billion in net outflows for the second straight week, while bitcoin trades in a tigh...
JPMorgan Nasdaq Equity Premium Income ETF appears to offer steady monthly income, but a closer look at its equity-lin...
Bitcoin traded near $75,000 after a sharp one-day drop, stoking debate over whether a single ETF block trade triggere...
Vanguard’s FTSE Developed Markets ETF has posted stronger gains than the S&P 500 in 2026, drawing renewed investor in...
The memory ETF DRAM fell 15% in one day as a guidance miss sparked a broader selloff, underscoring the risk of a conc...